Sign Up

List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
Interview with the CSO of Bright Minds Biosciences Dr Jan Torleif Pedersen

Interview with the CSO of Bright Minds Biosciences, Dr. Jan Torleif Pedersen

May 31, 2023

Clinical Stage
BioNeex Interview with the CEO of LIDDS, Anders Månsson

Interview with the CEO of LIDDS, Anders Månsson

Mar 28, 2023

Cancer Therapies
BioNeex Interview with AP, Oncology Lead at CHBC, Dr. James T. Lee discussing Cancer Progress

Interview with AP, Oncology Lead at CHBC, Dr. James T. Lee discussing Cancer Progress

Apr 23, 2019

Gene Therapy
BioNeex Interview with Associate Principal at CHBC, Dr. Joel S. Sandler discussing Cancer Progress

Interview with Associate Principal at CHBC, Dr. Joel S. Sandler discussing Cancer Progress

Apr 23, 2019

Gene Therapy
BioNeex Interview with CEO of American Gene Technologies Jeff Galvin

Interview with CEO of American Gene Technologies, Jeff Galvin

Apr 26, 2020

Gene Therapy
BioNeex Interview with CEO of Audacity Therapeutics Barbara Handelin

Interview with CEO of Audacity Therapeutics, Barbara Handelin

Oct 25, 2019

Clinical Stage
BioNeex Interview with CEO of StemTek Therapeutics Dr Angel Garcia Martin

Interview with CEO of StemTek Therapeutics, Dr. Angel Garcia Martin

Apr 24, 2019

Gene Therapy
BioNeex Interview with Executive Chairman & Founder of CHBC, Ed Saltzman discussing Cancer Progress

Interview with Executive Chairman & Founder of CHBC, Ed Saltzman discussing Cancer Progress

Apr 23, 2019

Gene Therapy
BioNeex Interview with Jeff Bockman, PhD - Trends and Future Insights in the Immuno-Oncology Space

Interview with Jeff Bockman, PhD – Trends and Future Insights in the Immuno-Oncology Space

Oct 17, 2018

Gene Therapy